SCHEMBL7708901

SCHEMBL7708901

COC(=O)C(C)NCC(O[Si](C)(C)C(C)(C)C)c1cccc(Cl)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.39
CYP2C19 P33261 2/20 0.39
CHRNA1 P02708 1/20 0.39
CHRNG P07510 1/20 0.39
ITGA5 P08648 1/20 0.39
CHRNB1 P11230 1/20 0.39
CHRNB2 P17787 1/20 0.39
CHRNB4 P30926 1/20 0.39
SLC6A4 P31645 1/20 0.39
CHRNA3 P32297 1/20 0.39
HRH1 P35367 1/20 0.39
CHRNA7 P36544 1/20 0.39
OPRK1 P41145 1/20 0.39
CHRNA4 P43681 1/20 0.39
SLC6A3 Q01959 1/20 0.39
CHRND Q07001 1/20 0.39
KCNH2 Q12809 1/20 0.39
CYP2B6 P20813 1/20 0.39
ALDH1A1 P00352 1/20 0.39
BLM P54132 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8586761 0.90 ADRB3 (0.41) SLC6A2CYP2C19CHRNA1CHRNGITGA5
SCHEMBL8586756 0.90 ADRB3 (0.41) SLC6A2CYP2C19CHRNA1CHRNGITGA5
SCHEMBL7714914 0.81 ADRB3 (0.40) CYP2C19CYP2B6ALDH1A1SMN1; SMN2ADRB2
SCHEMBL7714916 0.81 ADRB3 (0.40) CYP2C19CYP2B6ALDH1A1SMN1; SMN2ADRB2
SCHEMBL7069969 0.81 ADRB3 (0.35) CYP2C19CYP2B6ADRB2ADRB3ADRB1
SCHEMBL7708906 0.80 ADRB3 (0.39) ADRB2ADRB3ADRB1GLAAOC3
SCHEMBL14833798 0.79 SLC6A2 (0.43) SLC6A2CYP2C19CHRNA1CHRNGITGA5
SCHEMBL7712663 0.79 SLC6A2 (0.43) SLC6A2CYP2C19CHRNA1CHRNGITGA5
SCHEMBL9063602 0.78 AOC3 (0.43) SLC6A2SLC6A4CYP2B6AOC3
SCHEMBL8405933 0.77 ADRB2 (0.51) CYP2C19ALDH1A1ADRB2ADRB3ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0865421-B1 ARYLETHANOLAMINE DERIVATIVES AND THEIR USE AS AGONISTS OF ATYPICAL BETA-ADRENOCEPTORS GLAXO GROUP LTD (GB) 2002-03-27 EP disclosed
US-6048872-A DIETETICS; ANTIDIABETIC AGENTS; CARDIOVASCULAR DISORDERS; GASTROINTESTINAL DISORDERS GLAXO WELLCOME INC. (US) 2000-04-11 US disclosed
EP-0865421-A1 ARYLETHANOLAMINE DERIVATIVES AND THEIR USE AS AGONISTS OF ATYPICAL BETA-ADRENOCEPTORS GLAXO GROUP LIMITED (GB) 1998-09-23 EP disclosed
WO-1997021665-A1 ARYLETHANOLAMINE DERIVATIVES AND THEIR USE AS AGONISTS OF ATYPICAL BETA-ADRENOCEPTORS GLAXO GROUP LIMITED (GB) 1997-06-19 WO disclosed
WO-1997021666-A1 ARYLETHANOLAMINE DERIVATIVES AND THEIR USE AS AGONISTS OF ATYPICAL BETA-ADRENOCEPTORS GLAXO GROUP LIMITED (GB) 1997-06-19 WO disclosed